Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Drug Discovery Technology Market Analysis and Forecast 2026-2030 | AI, Precision Medicine, and Digital Biology Drive USD 31.56 Billion Growth at 9.1% CAGR

globenewswire.com
AGNT Agilent Technologies Inc. is mentioned as a vendor in the global drug discovery technology market, which is projected for significant growth. The article does not provide specific sentiment towards Agilent. BDX Becton Dickinson and Co. is listed as a vendor in the drug discovery technology market. The article focuses on market growth and trends, not specific company performance. BIOA Bio-Rad Laboratories Inc. is identified as a vendor within the drug discovery technology market. The article highlights overall market expansion and does not offer specific sentiment for this company. BRKR Bruker Corp. is mentioned as a vendor in the drug discovery technology market. The article discusses market growth drivers and trends, without specific sentiment for Bruker. GLW Corning Inc. is listed as a vendor in the drug discovery technology market. The article forecasts market expansion and does not provide specific sentiment for Corning. DHR Danaher Corp. is mentioned as a vendor in the drug discovery technology market. The article highlights market growth drivers like AI and precision medicine, but lacks specific sentiment for Danaher. GSBC GenScript Biotech Corp. is identified as a vendor in the drug discovery technology market. The article discusses overall market expansion and does not provide specific sentiment for GenScript. ILMN Illumina Inc. is mentioned as a vendor in the drug discovery technology market. The article forecasts market growth driven by AI and precision medicine, but offers no specific sentiment for Illumina. MRK Merck KGaA is mentioned as a vendor in the drug discovery technology market. The article highlights market growth drivers and trends, without specific sentiment for Merck KGaA. RVTY Revvity Inc. is listed as a vendor in the drug discovery technology market. The article forecasts market expansion and does not provide specific sentiment for Revvity. TMO Thermo Fisher Scientific Inc. is mentioned as a vendor in the drug discovery technology market. The article highlights market growth drivers like AI and precision medicine, but offers no specific sentiment for Thermo Fisher.

Global Drug Discovery Technology Market Analysis and Forecast 2026-2030 | AI, Precision Medicine, and Digital Biology Drive USD 31.56 Billion Growth at 9.1% CAGR Dublin, Oct. 16, 2026 (GLOBE NEWSWIRE) -- "Global Drug Discovery Technology Market 2026-2030" has been added to ResearchAndMarkets.com's offering.

The global drug discovery technology market is projected to expand by USD 31.56 billion during 2025-2030, accelerating at a CAGR of 9.1% throughout the forecast period. Market growth is being supported by rising demand for precision medicine research, targeted therapeutics, digital biology solutions, and computational discovery platforms.

The report provides an up-to-date assessment of the global market, including market size, forecasts, industry trends, growth drivers, challenges, regional developments, and the competitive landscape. It also evaluates approximately 25 leading vendors to help pharmaceutical companies, biotechnology businesses, research organizations, and other stakeholders identify emerging opportunities and strengthen their market positions.

Strategic collaborations across the pharmaceutical and biotechnology ecosystem are becoming increasingly important as organizations seek to accelerate research, expand access to advanced technologies, and improve drug development outcomes. The expansion of externalized discovery ecosystems and platform based research models is also contributing to demand for integrated technologies and specialized research services.

Another major market trend is the shift toward multimodal biological data integration. Combining diverse biological datasets is expected to support more comprehensive research workflows and improve the identification and validation of therapeutic targets. Increasing use of real world and longitudinal data in discovery workflows is also anticipated to create sizable demand during the forecast period.

Market Segmentation by Product

Market Segmentation by End-User

Market Segmentation by Therapeutic Area

Geographic Coverage

The market analysis examines historical and forecast data alongside product, end-user, therapeutic area, and regional performance. Its findings are based on a combination of primary and secondary research, including input from key industry participants. Qualitative and quantitative methodologies are used to assess critical market parameters such as pricing, profitability, competition, and promotional activity.

The competitive analysis covers Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Bruker Corp., Carl Zeiss AG, Charles River Laboratories, Corning Inc., Danaher Corp., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Illumina Inc., Lonza Group Ltd., Merck KGaA, Promega Corp., QIAGEN N.V., Revvity Inc., Sartorius AG, Shimadzu Corp., Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Waters Corp.

Detailed vendor selection methodology and competitive benchmarking offer insight into the strategies, capabilities, and market positioning of key participants. The report also assesses upcoming trends and challenges that could influence investment decisions, technology adoption, strategic partnerships, and future market growth.

Overall, the global drug discovery technology market is positioned for sustained expansion as precision medicine, computational research, biological data integration, and collaborative discovery models become more prominent. Organizations investing in scalable platforms, advanced analytics, and integrated research capabilities are expected to be well placed to capture opportunities emerging through 2030.

Key Topics Covered:

1 Executive Summary

1.1 Market overview

2 Market Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation

2.3 Factors of disruption

2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem

3.2 Market characteristics

3.3 Value chain analysis

4 Market Sizing

4.1 Market definition

4.2 Market segment analysis

4.3 Market size 2025

4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global Drug Discovery Technology Market 2020 - 2024

5.2 Product segment analysis 2020 - 2024

5.3 End-user segment analysis 2020 - 2024

5.4 Therapeutic Area segment analysis 2020 - 2024

5.5 Geography segment analysis 2020 - 2024

5.6 Country segment analysis 2020 - 2024

6 Qualitative Analysis

6.1 Impact of AI on global drug discovery technology market

6.2 Impact of geopolitical conflicts on global drug discovery technology market

7 Five Forces Analysis

7.1 Five forces summary

7.2 Bargaining power of buyers

7.3 Bargaining power of suppliers

7.4 Threat of new entrants

7.5 Threat of substitutes

7.6 Threat of rivalry

7.7 Market condition

8 Market Segmentation by Product

8.1 Market segments

8.2 Comparison by Product

8.3 Genomics - Market size and forecast 2025-2030

8.4 Proteomics - Market size and forecast 2025-2030

8.5 Bioinformatics - Market size and forecast 2025-2030

8.6 HTS - Market size and forecast 2025-2030

8.7 Others - Market size and forecast 2025-2030

8.8 Market opportunity by Product

9 Market Segmentation by End-user

9.1 Market segments

9.2 Comparison by End-user

9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030

9.4 Academic and research institutes - Market size and forecast 2025-2030

9.5 CROs - Market size and forecast 2025-2030

9.6 Market opportunity by End-user

10 Market Segmentation by Therapeutic Area

10.1 Market segments

10.2 Comparison by Therapeutic Area

10.3 Oncology - Market size and forecast 2025-2030

10.4 Neurology - Market size and forecast 2025-2030

10.5 CVD - Market size and forecast 2025-2030

10.6 Infectious diseases - Market size and forecast 2025-2030

10.7 Others - Market size and forecast 2025-2030

10.8 Market opportunity by Therapeutic Area

11 Customer Landscape

11.1 Customer landscape overview

12 Geographic Landscape

12.1 Geographic segmentation

12.2 Geographic comparison

12.3 North America - Market size and forecast 2025-2030

12.3.1 US - Market size and forecast 2025-2030

12.3.2 Canada - Market size and forecast 2025-2030

12.3.3 Mexico - Market size and forecast 2025-2030

12.4 Europe - Market size and forecast 2025-2030

12.4.1 Germany - Market size and forecast 2025-2030

12.4.2 UK - Market size and forecast 2025-2030

12.4.3 France - Market size and forecast 2025-2030

12.4.4 Italy - Market size and forecast 2025-2030

12.4.5 Spain - Market size and forecast 2025-2030

12.4.6 The Netherlands - Market size and forecast 2025-2030

12.5 Asia - Market size and forecast 2025-2030

12.5.1 China - Market size and forecast 2025-2030

12.5.2 India - Market size and forecast 2025-2030

12.5.3 Japan - Market size and forecast 2025-2030

12.5.4 South Korea - Market size and forecast 2025-2030

12.5.5 Indonesia - Market size and forecast 2025-2030

12.5.6 Thailand - Market size and forecast 2025-2030

12.6 Rest of World (ROW) - Market size and forecast 2025-2030

12.6.1 Brazil - Market size and forecast 2025-2030

12.6.2 Australia - Market size and forecast 2025-2030

12.6.3 Saudi Arabia - Market size and forecast 2025-2030

12.6.4 UAE - Market size and forecast 2025-2030

12.6.5 Argentina - Market size and forecast 2025-2030

12.6.6 Colombia - Market size and forecast 2025-2030

12.6.7 South Africa - Market size and forecast 2025-2030

12.6.8 Israel - Market size and forecast 2025-2030

12.7 Market opportunity by geography

13 Drivers, Challenges, and Opportunity

13.1 Market drivers

13.2 Market challenges

13.3 Impact of drivers and challenges

13.4 Market opportunities

14 Competitive Landscape

14.1 Overview

14.2 Competitive Landscape

14.3 Landscape disruption

14.4 Industry risks

15 Competitive Analysis

15.1 Companies profiled

15.2 Company ranking index

15.3 Market positioning of companies

15.4 Becton Dickinson and Co.

15.5 Carl Zeiss AG

15.6 Corning Inc.

15.7 Danaher Corp.

15.8 Eppendorf SE

15.9 Eurofins Scientific SE

15.10 F. Hoffmann La Roche Ltd.

15.11 GenScript Biotech Corp.

15.12 Illumina Inc.

15.13 Lonza Group Ltd.

15.14 Merck KGaA

15.15 Revvity Inc.

15.16 Sartorius AG

15.17 Shimadzu Corp.

15.18 Thermo Fisher Scientific Inc.

16 Appendix

16.1 Scope of the report

16.2 Inclusions and exclusions checklist

16.3 Currency conversion rates for US$

16.4 Research methodology

16.5 Data procurement

16.6 Data validation

16.7 Validation techniques employed for market sizing

16.8 Data synthesis

16.9 360 degree market analysis

16.10 List of abbreviations

List of Exhibits [327]

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this report visit https://www.researchandmarkets.com/r/egz0cn

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.